Goldman Sachs’s Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant IBER.U Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-54,762	Closed	-$540K	–	5672
2021 Q1	$540K	Buy	+54,762	New	+$540K	﹤0.01%	4302